Facebook Linkedin RSS Twitter Youtube
Home 2023

Phase II clinical trials (Drug development)

Weaker Tumor Microenvironments, Stronger Immunotherapies
Cancer

Weaker Tumor Microenvironments, Stronger Immunotherapies

BioNTech, DualityBio Ink Up-to-$1.7B Cancer ADC Collaboration
Cancer

BioNTech, DualityBio Ink Up-to-$1.7B Cancer ADC Collaboration

Developing the Next Generation of SARS-CoV-2 Vaccines
Coronavirus

Developing the Next Generation of SARS-CoV-2 Vaccines

Alto Neuroscience Announces Positive Phase II Results Supporting Precision Psychiatry Platform
Drug Discovery

Alto Neuroscience Announces Positive Phase II Results Supporting Precision Psychiatry Platform

Novavax Initiates Phase II Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccines
Coronavirus

Novavax Initiates Phase II Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccines

COVID-19 Treatment Hope Found in Anti-Inflammatory Drug
Coronavirus

COVID-19 Treatment Hope Found in Anti-Inflammatory Drug

After Seven Patient Deaths, MacroGenics Halts Phase II Trial
Cancer

After Seven Patient Deaths, MacroGenics Halts Phase II Trial

Potential Therapeutic Targets in Multiple Sclerosis Identified by Novel Method
Drug Discovery

Potential Therapeutic Targets in Multiple Sclerosis Identified by Novel Method

Malaria Drug Could Combat Head and Neck Cancer Chemotherapy Resistance
Cancer

Malaria Drug Could Combat Head and Neck Cancer Chemotherapy Resistance

1234...61Page 3 of 61
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.